$MET

MetLife Pension Settlement: How Outdated Math Shorted Thousands of Retirees for Years

MetLife settled a class-action lawsuit for $23 million, resolving claims that it underpaid retirees by using outdated actuarial tables. The case, McAlister et al. v. MetLife, alleged violations of ERISA. The settlement covers retirees who received benefits under various MetLife plans since 2013. MetLife's Retirement Plan had over 13,200 members and $7.9 billion in assets as of 2024.

Original reporting
Published Aug 21, 2026, 6:33 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 10:51 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MetLife Pension Settlement: How Outdated Math Shorted Thousands of Retirees for Years — source image
Decision brief

The 30-second read

$METNeutralLow
01

Why it matters

Resolution removes litigation risk but the $23 M payout is minor relative to the pension plan's size.

02

Market read

Legal settlement clears a pending risk for MetLife; modest financial impact, but may influence sector-wide actuarial practices.

03

What to watch

Potential future regulatory changes to actuarial tables could increase costs for pension sponsors beyond this settlement.

Relevance 5/10Novelty 6/10Timing: post‑settlement announcement

Background

MetLife faced a class-action lawsuit alleging use of outdated mortality tables, leading to underpayment of retirees.

Company-level read

Ticker impact

$METNeutralMedium confidence
Context

MetLife disclosed a $23 million settlement of an ERISA pension lawsuit, the first public report of the agreement.

Expected impact

Small upside potential as legal risk is cleared; no immediate price shock expected.

Evidence & confidence

Settlement amount is small relative to MetLife's $7.9 bn pension plan assets; market may view risk removal favorably.

Market effects

Highlights potential scrutiny of pension plan actuarial assumptions across insurers, could prompt reviews in the insurance sector.

Primarily U.S. insurance market; limited broader regional effect.

Sets a precedent for ERISA litigation globally, but limited immediate global market impact.

Counterpoint

The settlement amount is negligible; investors may view the news as a distraction and focus on core insurance earnings.

Key entities

  • MetLife

    U.S. insurer and pension plan sponsor.

  • McAlister et al.

    Retiree class alleging underpayment.

Related articles

$METMedAI 8/10

Is MetLife Outperforming the Nasdaq?

MetLife (MET) has outperformed the Nasdaq Composite, with shares up 22.5% year-to-date and 32.6% over 52 weeks. The company reported a 15.5% increase in adjusted earnings and 7% revenue growth in Q2 2026. Analysts have a 'Moderate Buy' rating with a mean price target of $106.23.

$METMedAI 8/10

MetLife (MET) Q2 2026 Earnings Call Transcript

MetLife (MET) Q2 2026 earnings call reported adjusted earnings of about $1.6 billion, or $2.43 per share, up 15% year over year. Adjusted premiums, fees and other revenues rose 5% (excluding pension risk transfers). Sales increased 7%, led by international growth. MetLife repurchased about $700 million of shares in the quarter and announced a new $3 billion authorization.

$METMed

MetLife Q2 Earnings Call Highlights

MetLife (NYSE:MET) reported Q2 expense ratio of 12.1%, up from 11.7% a year ago, citing a ~50 bps PineBridge Investments impact. Management said it is on track to beat its 12.1% full-year 2026 target. Group Benefits adjusted earnings rose to $503m, RIS to $377m, and MIM to $57m, with multiple segment margin and sales updates.

$METMed

MetLife reports $1.6bn adjusted earnings in second quarter 2026

MetLife reported second-quarter 2026 adjusted earnings of $1.6bn. Net investment income rose 18% to $6.7bn. Book value per share increased 8% to $38.59 and adjusted book value per share rose 3% to $57.71. The company returned over $1.1bn to shareholders via buybacks and dividends, and reported segment adjusted earnings gains across Group Benefits, Retirement and Income Solutions, Asia, EMEA, and MetLife Investment Management.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.